Review of Quality Control Record and Analytical Data by Dr. A. AmsavelDr. Amsavel A
Review of Quality Control Record and Analytical Data
Objective and Requirement for Analytical data review
Role of Analyst and reviewer,
Procedure and checklist for review of records/data
Review of traceable /associated documents
Review of calibration, Reference standard record, sampling reports,
Review of Audit trail
Role of Analyst & Reviewer
Review of chromatograms& audit trail,
Data Integrity & Good Record Practice
FDA Citations
Almost all the regulatory bodies are expected to have Risk Based Quality System. Quality Risk and its assessment has tremendous output and benefits towards the Patient Safety.
Review of Quality Control Record and Analytical Data by Dr. A. AmsavelDr. Amsavel A
Review of Quality Control Record and Analytical Data
Objective and Requirement for Analytical data review
Role of Analyst and reviewer,
Procedure and checklist for review of records/data
Review of traceable /associated documents
Review of calibration, Reference standard record, sampling reports,
Review of Audit trail
Role of Analyst & Reviewer
Review of chromatograms& audit trail,
Data Integrity & Good Record Practice
FDA Citations
Almost all the regulatory bodies are expected to have Risk Based Quality System. Quality Risk and its assessment has tremendous output and benefits towards the Patient Safety.
Documentation with respect to release of finished pharmaceutical productMadhuraNewrekar
Documentation is a crucial part of the quality assurance system and is needed in every aspect of pharmaceutical manufacturing. Important documentation with respect to final product release in pharmaceutical industry is explained in brief.
GLP is a quality system concerned with the organizational process and the conditions, under which non-clinical health and environmental safety studies are planned, performed, monitored, recorded, archived and reported.
I am uploading this GMP presentation to make aware who are working in pharma and help to maintain high standards in products manufacturing .
GMP Vs cGMP: It is my understanding that , Ultimately GMP & cGMP both the aim is same, means to prevention of the product from bad quality entering the market to endover peoples's life.
GMP applies to pharmaceutical and healthcare products and help to maintain high standards in these products.
cGMP is to remind accepting countries that all guidelines must be followed with latest and current production processes i.e employ technologies and systems which are up-to-date in order to comply with the regulation.
FDA (Food and Drug Administration) included the word “current” to ensure that regulated firms use the most current Good Manufacturing Practices (I believe that some firms would actually use outdated versions of the GMP’s to manufacture regulated products.
(the FDA have made their standards immediately identifiable i.e cGMP; Other international bodies such as the ICH, WHO use the term GMP, as do Canada, Japan and the EMEA (European authority). In FDA view cGMP means following 21 CFR 210 and 211 and no other.)
Good Laboratory Practices (GLP)
History
Reason behind GLP created
Advantages and disadvantages of GLP
Objectives of GLP
Practice of GLP
b pharma 6th sem
pharmaceutical quality assurance
Drug Discovery path
Pharma R & D –overview
Discovery & Development
Preclinical research
Clinical Trial
NDA and FDA Approval
Post marketing data
References
Optical Rotation and Polarimeter by Dr. A. AmsavelDr. Amsavel A
Isomers and enantiomers
Specific Optical Rotation
Polarimeter
Instrumentation and Operation
Factors affect the Optical Rotation
Calibration
Application Specifically Pharmaceutical Industries
Personal Hygiene for pharma industry-Dr. A. AmsavelDr. Amsavel A
Personal hygiene
Source of Contamination and control
GMP Requirement /Guideline
Procedures & Records
Protective Clothing & gowning
Health Examination
Hand wash – How and when
Training & Practice
by Dr. A. Amsavel
Awareness on Cancer
what are the causes for cancer
Terminology
Classification of Cancers
Signs and Symptoms
Stages of Cancers (TSM)
Types of Cancer Treatments
Surgery, Chemotherapy, Radiation Therapy etc
Side effects on treatment
Palliative care
FTIR SPECTROSCOPY,
Principle, Theory, Instrumentation and Application in Pharmaceutical Industry
IR Spectroscopy- Absorption Theory
Type of Vibrations & Vibration Energy level
FTIR Spectrophotometer-Instrumentation
Operation of the Spectrophotometer
Qualification & Calibration
IR Absorption by Organic compounds
Application
FDA citation in FTIR Analysis-Pharmaceutical Industries
UV -Vis Spectrophotometry- Principle, Theory, Instrumentation and Application...Dr. Amsavel A
UV -Vis Spectrophotometry- Principle, Theory, Instrumentation and Application in Pharmaceutical Industry Dr. A. Amsavel.
UV &Visible Spectroscopy-Absorption Theory
Electronic Transitions
Beer- Lambert Law
Chromophores & Auxochrome
Factors Influence the Absorption
UV-Vis Spectrophotometer-Instrumentation
Operation of the Spectrophotometer
Qualification & Calibration
Application
Handling of Refernce Standards_Dr.A.Amsavel Dr. Amsavel A
Definition
Requirements
Guidelines
Pharmacopiea
Types of Reference Standards
SOP for handling of Reference Standards
Qualification of Secondary Standards
Assigning Potency, Storage and Use
Documents & Records
Contamination Control in Cleanrooms_Dr.A. AmsavelDr. Amsavel A
Basic’s of Contamination
Sources of Contamination
Environment Specification
Elements of Cleanroom Design and Qualification
Definitions
Control of Contaminations
People, Cleaning, Environment & Material
Operation, Monitoring and Control
Documents and Records
Handling of Customer Complaint_Dr.A.AmsavelDr. Amsavel A
Reference Guideline
Definitions
GMP Requirement: 21 CFR § 211.198 and ICH Q7
Procedure for Handling of Complaints
Complaint Investigation
Remedial action and CAPA
Report preparation
Response to customer
Verification of CAPA effectiveness
Review of Complaints
Volumetric Analysis
Titration Basics
Reaction, End point & Indicators
Types of Titrations
Acid – Base Theory & Principles
Acid Base titration
Non- Aqueous Titration
Precipitation Titration
Complexometric Titration
Oxidation- Reduction Titration
Calculation
General Information
Errors
Volumetric Analysis
Types of titration
Acid- Base Theory
Reaction, End Point & Indicators
Acid- Base titration
Titration curve
Non- Aqueous Titration
Precipitation Titration
Complexometric Titration
Oxidation- Reduction Titration,
Calculation. Errors
General Informations,
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journeygreendigital
Tom Selleck, an enduring figure in Hollywood. has captivated audiences for decades with his rugged charm, iconic moustache. and memorable roles in television and film. From his breakout role as Thomas Magnum in Magnum P.I. to his current portrayal of Frank Reagan in Blue Bloods. Selleck's career has spanned over 50 years. But beyond his professional achievements. fans have often been curious about Tom Selleck Health. especially as he has aged in the public eye.
Follow us on: Pinterest
Introduction
Many have been interested in Tom Selleck health. not only because of his enduring presence on screen but also because of the challenges. and lifestyle choices he has faced and made over the years. This article delves into the various aspects of Tom Selleck health. exploring his fitness regimen, diet, mental health. and the challenges he has encountered as he ages. We'll look at how he maintains his well-being. the health issues he has faced, and his approach to ageing .
Early Life and Career
Childhood and Athletic Beginnings
Tom Selleck was born on January 29, 1945, in Detroit, Michigan, and grew up in Sherman Oaks, California. From an early age, he was involved in sports, particularly basketball. which played a significant role in his physical development. His athletic pursuits continued into college. where he attended the University of Southern California (USC) on a basketball scholarship. This early involvement in sports laid a strong foundation for his physical health and disciplined lifestyle.
Transition to Acting
Selleck's transition from an athlete to an actor came with its physical demands. His first significant role in "Magnum P.I." required him to perform various stunts and maintain a fit appearance. This role, which he played from 1980 to 1988. necessitated a rigorous fitness routine to meet the show's demands. setting the stage for his long-term commitment to health and wellness.
Fitness Regimen
Workout Routine
Tom Selleck health and fitness regimen has evolved. adapting to his changing roles and age. During his "Magnum, P.I." days. Selleck's workouts were intense and focused on building and maintaining muscle mass. His routine included weightlifting, cardiovascular exercises. and specific training for the stunts he performed on the show.
Selleck adjusted his fitness routine as he aged to suit his body's needs. Today, his workouts focus on maintaining flexibility, strength, and cardiovascular health. He incorporates low-impact exercises such as swimming, walking, and light weightlifting. This balanced approach helps him stay fit without putting undue strain on his joints and muscles.
Importance of Flexibility and Mobility
In recent years, Selleck has emphasized the importance of flexibility and mobility in his fitness regimen. Understanding the natural decline in muscle mass and joint flexibility with age. he includes stretching and yoga in his routine. These practices help prevent injuries, improve posture, and maintain mobilit
263778731218 Abortion Clinic /Pills In Harare ,sisternakatoto
263778731218 Abortion Clinic /Pills In Harare ,ABORTION WOMEN’S CLINIC +27730423979 IN women clinic we believe that every woman should be able to make choices in her pregnancy. Our job is to provide compassionate care, safety,affordable and confidential services. That’s why we have won the trust from all generations of women all over the world. we use non surgical method(Abortion pills) to terminate…Dr.LISA +27730423979women Clinic is committed to providing the highest quality of obstetrical and gynecological care to women of all ages. Our dedicated staff aim to treat each patient and her health concerns with compassion and respect.Our dedicated group ABORTION WOMEN’S CLINIC +27730423979 IN women clinic we believe that every woman should be able to make choices in her pregnancy. Our job is to provide compassionate care, safety,affordable and confidential services. That’s why we have won the trust from all generations of women all over the world. we use non surgical method(Abortion pills) to terminate…Dr.LISA +27730423979women Clinic is committed to providing the highest quality of obstetrical and gynecological care to women of all ages. Our dedicated staff aim to treat each patient and her health concerns with compassion and respect.Our dedicated group of receptionists, nurses, and physicians have worked together as a teamof receptionists, nurses, and physicians have worked together as a team wwww.lisywomensclinic.co.za/
Here is the updated list of Top Best Ayurvedic medicine for Gas and Indigestion and those are Gas-O-Go Syp for Dyspepsia | Lavizyme Syrup for Acidity | Yumzyme Hepatoprotective Capsules etc
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...Oleg Kshivets
Overall life span (LS) was 1671.7±1721.6 days and cumulative 5YS reached 62.4%, 10 years – 50.4%, 20 years – 44.6%. 94 LCP lived more than 5 years without cancer (LS=2958.6±1723.6 days), 22 – more than 10 years (LS=5571±1841.8 days). 67 LCP died because of LC (LS=471.9±344 days). AT significantly improved 5YS (68% vs. 53.7%) (P=0.028 by log-rank test). Cox modeling displayed that 5YS of LCP significantly depended on: N0-N12, T3-4, blood cell circuit, cell ratio factors (ratio between cancer cells-CC and blood cells subpopulations), LC cell dynamics, recalcification time, heparin tolerance, prothrombin index, protein, AT, procedure type (P=0.000-0.031). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and N0-12 (rank=1), thrombocytes/CC (rank=2), segmented neutrophils/CC (3), eosinophils/CC (4), erythrocytes/CC (5), healthy cells/CC (6), lymphocytes/CC (7), stick neutrophils/CC (8), leucocytes/CC (9), monocytes/CC (10). Correct prediction of 5YS was 100% by neural networks computing (error=0.000; area under ROC curve=1.0).
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
ABDOMINAL TRAUMA in pediatrics part one.drhasanrajab
Abdominal trauma in pediatrics refers to injuries or damage to the abdominal organs in children. It can occur due to various causes such as falls, motor vehicle accidents, sports-related injuries, and physical abuse. Children are more vulnerable to abdominal trauma due to their unique anatomical and physiological characteristics. Signs and symptoms include abdominal pain, tenderness, distension, vomiting, and signs of shock. Diagnosis involves physical examination, imaging studies, and laboratory tests. Management depends on the severity and may involve conservative treatment or surgical intervention. Prevention is crucial in reducing the incidence of abdominal trauma in children.
Title: Sense of Taste
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the structure and function of taste buds.
Describe the relationship between the taste threshold and taste index of common substances.
Explain the chemical basis and signal transduction of taste perception for each type of primary taste sensation.
Recognize different abnormalities of taste perception and their causes.
Key Topics:
Significance of Taste Sensation:
Differentiation between pleasant and harmful food
Influence on behavior
Selection of food based on metabolic needs
Receptors of Taste:
Taste buds on the tongue
Influence of sense of smell, texture of food, and pain stimulation (e.g., by pepper)
Primary and Secondary Taste Sensations:
Primary taste sensations: Sweet, Sour, Salty, Bitter, Umami
Chemical basis and signal transduction mechanisms for each taste
Taste Threshold and Index:
Taste threshold values for Sweet (sucrose), Salty (NaCl), Sour (HCl), and Bitter (Quinine)
Taste index relationship: Inversely proportional to taste threshold
Taste Blindness:
Inability to taste certain substances, particularly thiourea compounds
Example: Phenylthiocarbamide
Structure and Function of Taste Buds:
Composition: Epithelial cells, Sustentacular/Supporting cells, Taste cells, Basal cells
Features: Taste pores, Taste hairs/microvilli, and Taste nerve fibers
Location of Taste Buds:
Found in papillae of the tongue (Fungiform, Circumvallate, Foliate)
Also present on the palate, tonsillar pillars, epiglottis, and proximal esophagus
Mechanism of Taste Stimulation:
Interaction of taste substances with receptors on microvilli
Signal transduction pathways for Umami, Sweet, Bitter, Sour, and Salty tastes
Taste Sensitivity and Adaptation:
Decrease in sensitivity with age
Rapid adaptation of taste sensation
Role of Saliva in Taste:
Dissolution of tastants to reach receptors
Washing away the stimulus
Taste Preferences and Aversions:
Mechanisms behind taste preference and aversion
Influence of receptors and neural pathways
Impact of Sensory Nerve Damage:
Degeneration of taste buds if the sensory nerve fiber is cut
Abnormalities of Taste Detection:
Conditions: Ageusia, Hypogeusia, Dysgeusia (parageusia)
Causes: Nerve damage, neurological disorders, infections, poor oral hygiene, adverse drug effects, deficiencies, aging, tobacco use, altered neurotransmitter levels
Neurotransmitters and Taste Threshold:
Effects of serotonin (5-HT) and norepinephrine (NE) on taste sensitivity
Supertasters:
25% of the population with heightened sensitivity to taste, especially bitterness
Increased number of fungiform papillae
Recomendações da OMS sobre cuidados maternos e neonatais para uma experiência pós-natal positiva.
Em consonância com os ODS – Objetivos do Desenvolvimento Sustentável e a Estratégia Global para a Saúde das Mulheres, Crianças e Adolescentes, e aplicando uma abordagem baseada nos direitos humanos, os esforços de cuidados pós-natais devem expandir-se para além da cobertura e da simples sobrevivência, de modo a incluir cuidados de qualidade.
Estas diretrizes visam melhorar a qualidade dos cuidados pós-natais essenciais e de rotina prestados às mulheres e aos recém-nascidos, com o objetivo final de melhorar a saúde e o bem-estar materno e neonatal.
Uma “experiência pós-natal positiva” é um resultado importante para todas as mulheres que dão à luz e para os seus recém-nascidos, estabelecendo as bases para a melhoria da saúde e do bem-estar a curto e longo prazo. Uma experiência pós-natal positiva é definida como aquela em que as mulheres, pessoas que gestam, os recém-nascidos, os casais, os pais, os cuidadores e as famílias recebem informação consistente, garantia e apoio de profissionais de saúde motivados; e onde um sistema de saúde flexível e com recursos reconheça as necessidades das mulheres e dos bebês e respeite o seu contexto cultural.
Estas diretrizes consolidadas apresentam algumas recomendações novas e já bem fundamentadas sobre cuidados pós-natais de rotina para mulheres e neonatos que recebem cuidados no pós-parto em unidades de saúde ou na comunidade, independentemente dos recursos disponíveis.
É fornecido um conjunto abrangente de recomendações para cuidados durante o período puerperal, com ênfase nos cuidados essenciais que todas as mulheres e recém-nascidos devem receber, e com a devida atenção à qualidade dos cuidados; isto é, a entrega e a experiência do cuidado recebido. Estas diretrizes atualizam e ampliam as recomendações da OMS de 2014 sobre cuidados pós-natais da mãe e do recém-nascido e complementam as atuais diretrizes da OMS sobre a gestão de complicações pós-natais.
O estabelecimento da amamentação e o manejo das principais intercorrências é contemplada.
Recomendamos muito.
Vamos discutir essas recomendações no nosso curso de pós-graduação em Aleitamento no Instituto Ciclos.
Esta publicação só está disponível em inglês até o momento.
Prof. Marcus Renato de Carvalho
www.agostodourado.com
These lecture slides, by Dr Sidra Arshad, offer a quick overview of the physiological basis of a normal electrocardiogram.
Learning objectives:
1. Define an electrocardiogram (ECG) and electrocardiography
2. Describe how dipoles generated by the heart produce the waveforms of the ECG
3. Describe the components of a normal electrocardiogram of a typical bipolar lead (limb II)
4. Differentiate between intervals and segments
5. Enlist some common indications for obtaining an ECG
6. Describe the flow of current around the heart during the cardiac cycle
7. Discuss the placement and polarity of the leads of electrocardiograph
8. Describe the normal electrocardiograms recorded from the limb leads and explain the physiological basis of the different records that are obtained
9. Define mean electrical vector (axis) of the heart and give the normal range
10. Define the mean QRS vector
11. Describe the axes of leads (hexagonal reference system)
12. Comprehend the vectorial analysis of the normal ECG
13. Determine the mean electrical axis of the ventricular QRS and appreciate the mean axis deviation
14. Explain the concepts of current of injury, J point, and their significance
Study Resources:
1. Chapter 11, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 9, Human Physiology - From Cells to Systems, Lauralee Sherwood, 9th edition
3. Chapter 29, Ganong’s Review of Medical Physiology, 26th edition
4. Electrocardiogram, StatPearls - https://www.ncbi.nlm.nih.gov/books/NBK549803/
5. ECG in Medical Practice by ABM Abdullah, 4th edition
6. Chapter 3, Cardiology Explained, https://www.ncbi.nlm.nih.gov/books/NBK2214/
7. ECG Basics, http://www.nataliescasebook.com/tag/e-c-g-basics
1. Good Laboratory PracticesGood Laboratory PracticesGood Laboratory PracticesGood Laboratory Practices
Dr. A. Amsavel
1
2. Good Laboratory Practices
in Pharmaceutical
Quality Control Laboratory
Reference: GMP Guidelines
◦ ICH Q7: specifically Chapters 6, 7, 11, 12 &13
◦ 21CFR 210 & 211
◦ Schedule L1
2
3. ContentContent
Definition
Requirements
QC Lab Management
QC personal
Sample Management
Reagents & Reference standard Reagents & Reference standard
Instruments and Calibration
Computer System Validation
Analysis, analytical data & Review
Reserve sample
Purposes of GMP Documentation
Tips to good documentation practices
Warning letters and observations
3
4. Definition (WHO)Definition (WHO)
Analytical worksheet
A printed form, an analytical workbook or electronic means (e-
records) for recording information about the sample, as well as
reagents and solvents used, test procedure applied, calculations
made, results and any other relevant information or comments .
Measurement uncertaintyMeasurement uncertainty
Non-negative parameter characterizing the dispersion of
quantity values being attributed to a measurand (analyte),
based on the information used
Metrological traceability
Property of a measurement result whereby the result can be
related to a reference through a documented, unbroken chain of
calibrations, each contributing to the measurement uncertainty.
4
5. Definition (WHO)Definition (WHO)
Deviation:
Deviation from the prescribed procedure
Out-Of-Specifi cation (OOS) result
All test results that fall outside the specifications or acceptance
criteria established in product dossiers, drug master files,criteria established in product dossiers, drug master files,
pharmacopoeias or by the manufacturer
Reference substance (or standard)
An authenticated, uniform material that is intended for use in
specified chemical and physical tests, in which its properties are
compared with those of the product under examination, and which
possesses a degree of purity adequate for its intended use
5
6. ICH Q7:RequirementICH Q7:Requirement
6.0 DOCUMENTATION AND RECORDS
6.1 Documentation System and Specifications
6.3 Records of Raw Materials, Intermediates, API.& Packaging Materials
6.6 Laboratory Control Records
7.0 MATERIALS MANAGEMENT
7.3 Sampling and Testing of Incoming Production Materials
11.0 LABORATORY CONTROLS
11.1 General Controls11.1 General Controls
11.2 Testing of Intermediates and APIs
11.3 Validation of Analytical Procedures - see Section 12
11.4 Certificates of Analysis
11.5 Stability Monitoring of APIs
11.6 Expiry and Retest Dating
12. 0 VALIDATION
12.8 Validation of Analytical Methods.
13.0 CHANGE CONTROL etc
6
7. CFR ReferencesCFR References
21 CFR 58 GLP:
All data generated during performing of a study, (except
automated data collection systems), shall be recorded directly,
promptly, and legibly in ink.
All data entries shall be dated on the date of entry and signed or
initialed by the person entering the data.initialed by the person entering the data.
Any change in entries shall be made so as not to obscure the
original entry, shall indicate the reason for such change, and shall
be dated and signed or identified at the time of the change.
21 CFR 211.194 (a)
Verification of laboratory test data for “Accuracy, Completeness
compliance with established standards”
7
8. Laboratory ManagementLaboratory Management
Organization and management
Quality management systems
Control of documentation and records
Data processing equipment Data processing equipment
Personnel
Premises, equipment, instruments and other
devices
Working procedures,
documents and safety
8
9. Organization and ManagementOrganization and Management
Function to meet Regulatory requirements
Operate in accordance with GxP standards
Personnel
◦ Adequately Qualified , experienced and competent
◦ Managerial and technical positions to ensure
operation in accordance with quality systems
◦ No conflict of interest
Organizational chart and job descriptions
9
10. Organization and ManagementOrganization and Management
Adequate information flow
Traceability of the samples (from receipt to
test report completion)
Procedures (SOP), Work instruction & Procedures (SOP), Work instruction &
documents
Current specifications & test method
Safety procedures
MSDS
10
11. Documents in QCDocuments in QC
Documents & Procedures should ensure that:
Specifications, sampling plans, and test procedures should
be scientifically sound
Shall be current documents with Ref No. Version and Shall be current documents with Ref No. Version and
effective date
Authorized SOPs are available near points of use
Invalid documents are removed and replaced
Revised documents refer to the previous document
Documents are archived,
Staff are trained for the new and revised SOPs
11
12. RecordsRecords
Procedure for the identification, collection,
indexing, retrieval, storage, maintenance and
disposal of documents/records.
All original observations, calculations and
derived data, calibration, validation andderived data, calibration, validation and
verification records, etc. and final results must
be retained on record for an appropriate
period of time, e.g.
Records to contain sufficient information to
permit repetition of tests and traceability
12
13. RecordsRecords
Legible, readily retrievable, stored and
retained
In a suitable environment that will prevent
modification, damage or deterioration and/or
lossloss
Secure, confidential. Access restricted to
authorized personnel.
Electronic storage and signatures allowed -
restricted access and in conformance with
requirements for electronic records
13
14. QC personalQC personal
Organization chart
Personal shall have appropriate Qualification /education,
experience or trainings.
Job description for each person
Analyst qualification as per assigned work
Training & retraining to analyst, reviewer, validation & Training & retraining to analyst, reviewer, validation &
computer data evaluation
Training on
◦ Quality system procedures
◦ Pharmacopeia General chapters
◦ Test methods
◦ Operation & calibration of Instruments
14
15. General RequirementGeneral Requirement
Water used in the Lab shall be suitable for indented
use.
Washing of glassware shall be ensured and validated
Separate area for sample preparation Separate area for sample preparation
Separate oven for drying of glassware ( 60°C)
SOPs are available
Any deviation, OOS shll be reported and investigated.
CAPA shall be implemented and relevet reports
should be maintained
15
16. Sample ManagementSample Management
Written procedures for sampling methods for in-process
materials, intermediates, and APIs.
Sampling plans and procedures should be based on scientifically
sound
Samples should be representative of the batch of material
Sampling methods should specify the number of containers to be
sampled, which part of the container to sample, and the amount
of material in each container.
Sampling should be conducted at defined locations and to
prevent contamination
Containers from which samples are withdrawn should be opened
carefully and subsequently re-closed.
Containers should be marked to indicate that a sample
16
17. Sample ManagementSample Management
Label affixed to each container of the sample
Procedure for preparation of representative samples
Sampling activity shall be recorded and maintained
Storage of sample and prevent mix-up or contamination Storage of sample and prevent mix-up or contamination
Registration number allocated for every sample Eg.:
Registration number of the sample, date of receipt,
location of sample sent
In-process sample shall be obtained from production with
request and appropriate tests will analysis before testing
starts
17
18. ReagentsReagents
Reagents, chemicals, solvents and materials used in
tests and assays shall be appropriate quality
Reagents from reputed & approved suppliers
Preparation of reagents:
◦ SOPs and as recommended in pharmacopoeia
◦ Clear responsibility in job descriptions
Records for the preparation, and standardization of
volumetric solutions
Storage & validity of based on established stability
18
19. ReagentsReagents
Reagents shall be clearly labelled:
◦ the contents, the manufacturer, the date received and
opened, concentration, storage conditions, expiry or re-
test date
◦ the name, date of preparation, initials of person, expiry
date, concentrationdate, concentration
Volumetric solutions:
◦ the name, molarity or concentration, date of preparation,
the date of standardization and Normality/factor.
Transportation in original containers
When subdivided – into clean, fully labelled containers
19
20. Reference standardReference standard
Reference substances and reference materials
Assign a person responsible
Primary reference standards obtained from an officially
recognized source like Pharmacopoeia reference substances
/ certified RS
Use appropriate RS for testing, calibration, qualification Use appropriate RS for testing, calibration, qualification
of equipment, instruments or other devices
Registration and labelling
Ref / Identification number
Document the receipt & Label, batch number, etc
Log or reconciliation
Procurement evidence/ record
20
21. Reference standardReference standard
Record for reference standard
Ref No /identification No. of the material
Description of the material
Source & date of receipt
batch designation or other identification code
Potency , LOD any other details as appropriate
Intended use of the material (e.g. as an infrared reference
material, as an impurity reference material for thin-layer
chromatography, etc.)
location of storage in the laboratory, and any special
storage conditions
21
22. InIn--house Reference standard /house Reference standard /
Working standardWorking standard
Where a pharmacopeia RS is not available, in-house primary standard
should be established.
Appropriate testing should be performed to establish fully the identity
and purity of the primary reference standard.
Full characterization and assign potency or other quality attribute.
Qualification , characterization recordshould be maintained. Qualification , characterization recordshould be maintained.
Secondary reference standards (working standard) should be
appropriately prepared, identified, tested, approved, and stored.
The suitability should established by comparing against a primary
reference standard.
Secondary reference standard should be periodically re-qualified
Certificate of analysis with reference to PRS
Store at recommended condition with expiry date or retest date
22
23. Instrument & Testing devicesInstrument & Testing devices
Qualification, Calibration, validation and verification of
equipment, instruments and other devices
Control, weighing, measuring, monitoring, and testing
equipment critical for ensuring the quality of product should
be calibrated according to written procedures and an
established schedule.established schedule.
Calibration procedure can be used from Pharmacopiea
Qualification / requalification DQ, IQ, OQ, PQ as necessary
Performance verification at appropriate intervals
Unique identification / code no for equipment, instruments,
devices used for testing, verification and/or calibration
23
24. Instrument & Testing devicesInstrument & Testing devices
Schedule /plan for regular calibration & execution and
record
calibrations should be performed using standards
traceable to certified standards, if they exist.
Diplay labels indicating status of calibration and due date Diplay labels indicating status of calibration and due date
Records of these calibrations should be maintained.
Instruments that do not meet calibration criteria should
not be used.
Deviations from approved standards of calibration on
critical instruments should be investigated to determine if
these could have had an effect on the quality of the
intermediate(s)
24
25. Records related to InstrumentsRecords related to Instruments
Records kept of each item of equipment/
instrument
Dates, results and copies of reports, verifications and
certificates of all calibrations, adjustments, acceptance
criteria and the due date of the next qualification,
verification and/or calibrationverification and/or calibration
Maintenance carried out, and the maintenance plan
History of any damage, malfunction, modification or
repair
Use and “remarks or observations” made at the time
the equipment, instruments or devices were used
25
26. Analysis & RecordAnalysis & Record
Analytical worksheet
Analyst shall record the information about the sample, the
test procedure, calculations and the results of testing
Raw data shall ne controlled / issued by QA or as
appropriateappropriate
Provides documentary evidence either:
◦ to confirm that the sample is tested as per requirements
◦ to support an OOS result and investigation
A separate analytical worksheet for each numbered sample
Keep all the test data (different analysts/units) together.
26
27. Analytical worksheetAnalytical worksheet
Dates (request, start of analysis, and completion), Time as
required
Name and signature of the analyst
Description of the sample
Reference to the specifications and test methods and limits Reference to the specifications and test methods and limits
Test equipment used
Reference substance used
Result of the system suitability test
Reagents and solvents employed
Interpretation of the results and the final conclusions
Deviations and other remarks
Reviewed / Approved and signed by the supervisor
27
28. Analytical worksheetAnalytical worksheet
Recording the data immediately on the analytical worksheet
All graphical data attached or be traceable to an electronic record
◦ A complete record of all raw data generated during each test, in
addition to graphs, charts and spectra from laboratory
instrumentation,
Completed analytical worksheet signed by analyst(s), verified and Completed analytical worksheet signed by analyst(s), verified and
approved and signed by the supervisor
Mistakes and amended results:
◦ old and new information available
◦ signed and dated by the person making the correction
◦ reason for the change given on the worksheet
SOP for amending electronic worksheets and audit trail
Follow ALCOA principles
28
29. External testing LaboratoryExternal testing Laboratory
When specific tests are to be done outside the laboratory –
test request and samples transferred.
Ensure the external Lab is qualified and approved.
Ensure the Lab id approved by regulatory authority,Ensure the Lab id approved by regulatory authority,
Establish quality agreement
Declaration on following the requirement
Method validation, transfer as required.
Ensure the sample and Test procedures detailed are
provided and followed
Deviations/ OOS shall be investigated and documented
29
30. Validation of Analytical MethodsValidation of Analytical Methods
All analytical procedures used for testing should be
suitable for the intended use.
Analytical method shall be validated as appropriately
If validation in other Lab, perform method transfer
Pharmacopoeial methods to be confirmed as suitable
for use. If adapted for another use then to be validated
In case of a major change in
analytical procedure , it
shall be revalidated
30
31. System Suitability TestSystem Suitability Test
Ensure to follow System suitability test as appropriate
SS is an integral part of many analytical procedures
Shows that equipment, electronics, analytical operations
are appropriate/suitable for the samples to be analysed
To be performed prior to the analysis
In case of a large number of samples analyzed in sequence -
then appropriate system suitability tests are to be
performed throughout the sequence
Verification not required for basic pharmacopoeial methods
– E.g. pH, loss on drying and wet chemical methods
31
32. Review of Analytical ResultsReview of Analytical Results
Evaluation of test results
All test results shall be reviewed and evaluated
check that results are accurate , consistent and meeting
specifications
Doubtful (atypical) and OOS results investigated Doubtful (atypical) and OOS results investigated
(supervisor with the analyst). Checks may include (not
limited to):
◦ Appropriate procedures applied and followed correctly
◦ Discrepancies in raw data; calculations correct
◦ Qualified, calibrated equipment used; system suitability tests were
done and acceptable
◦ Glassware, reagents, solvents and reference substances used
Original sample kept until the investigation is complete
32
33. Review of Analytical recordReview of Analytical record
Proper review will prevent the Non-compliances/ observation;
Sincere and effective review shall be done; not just signing as
reviewer;
The following shall be reviewed but not limited to;
◦ Incomplete entries, signature
◦ missing records and out-prints
◦ Illegible entries / unacceptable corrections
◦ Traceability of relevant records /cross references
◦ Deviations, if any investigation the impact on the product
◦ Valid calibrations and service intervals of test equipment
◦ Compliance with specifications,
◦ Calculations
33
34. Review of Analytical DataReview of Analytical Data
SOP should be available to verify the accuracy, reliability, and
completeness of the Analytical data
Role & Responsibility : Define the Analysts, Reviewers, and
various level /lab managers
SOP Shall cover the data integrity principles
◦ ALCOA and + 2CEA◦ ALCOA and + 2CEA
Good document practice
Describe, How to review record s for accurate & completeness
Define , what are the record to be reviewed
Review of raw data /electronic data,
audit trail etc
Access & Privileges as required
34
35. Reserve sampleReserve sample
Pack & store the reserve samples is for the purpose of
potential future evaluation of the quality of batches of API
Appropriately identified reserve samples of each API batch
should be retained for 1 year after the expiry date or for 3
years after distribution of the batch, whichever is longer.
The reserve sample should be stored in the same The reserve sample should be stored in the same
packaging system in which the API is stored or in one that
is equivalent to or more protective than the marketed
packaging system.
Sufficient quantities should be retained to conduct at
least two full specification analyses
Verify the reserve sample periodically and record for
physical attribute
35
36. Computer System ValidationComputer System Validation
GMP-related computerized systems should be validated.
Appropriate installation and operational qualifications should
demonstrate the suitability of computer hardware and software to
perform assigned tasks.
Commercially available software that has been qualified does not require
the same level of testing.
Computerized systems should have sufficient controls to prevent
unauthorized access or changes to data. There should be controls to
prevent omissions in data (e.g., system turned off and data not
captured).
There should be a record of any data change made, the previous entry,
who made the change, and when the change was made.
SOP for the operation and maintenance of computerized systems.
Any critical data is manual, ensure an additional check on the accuracy of
the entry.
36
37. Computer System ValidationComputer System Validation
Incidents related to computerized systems that could affect the
quality of product or test results should be recorded and
investigated.
Changes to computerized systems should handled thorough
change procedure.
Record all changes, modifications and enhancements made to
the hardware, software, and critical component of the system to
ensure that the system is maintained in a validated state.
Records shall be a backed up. Ensure data protection all
computerized systems.
Data can be recorded by a second means in addition to the
computer system.
37
39. Importance of GMP DocumentationImportance of GMP Documentation
“If it hasn't been documented, then it hasn't
done or happened!”
“If it is not documented, it is a rumour!”
Famous FDA statementFamous FDA statement
The product considered as “Adulterated” if
the procedure not followed/ not
documented properly.
39
40. Data Integrity PrinciplesData Integrity Principles
ALCOA is an acronym representing the following
data integrity elements:
◦ Attributable – Who performed and when?
◦ Legible – Can it be read? Permanent Record◦ Legible – Can it be read? Permanent Record
◦ Contemporaneous – Recorded at the time the
activity was performed
◦ Original – Original record or certified
true copy
◦ Accurate – Error free
40
41. ALCOA DescriptionALCOA Description
ALCOA Description/Explanation
A Attributable Who performed an action and when?
If a record is amended / changed, who did it and
why?
Why- reason & explain in detail
Traceable to the source data.Traceable to the source data.
L Legible Data shall be recorded permanently
Record shall be durable & readable.
C Contempora
neous
The data shall be recorded at the time the work is
performed. Signature / initial with date
O Original Is the information the original record or a certified
true copy?
A Accurate No errors or if editing, shall be amended properly
41
42. ALCOA +ALCOA +
ALCOA + Description/Explanation
1 Complete All data including repeat or reanalysis
performed on the sample.
2 Consistent Consistent application of data time
stamps in the expected sequence
3 Enduring & Recorded on controlled worksheets,
laboratory notebooks, or electronic
media.
4 Available Available/accessible for review/audit for
the lifetime of the record.
42
43. Good Documentation PracticesGood Documentation Practices
All entries must be clear and legible
Never make erasures or write overs.
Do not scribble out or "white out" entries;
Thus, the integrity of the record will not be in question.
Any written error must be crossed out in such a manner that the Any written error must be crossed out in such a manner that the
original information is still legible.
The crossed out section must be initialed and dated by originator.
Corrections must be made adjacent to the deleted entry. Write
reason for correction eg Transposition, Illegible entry, Scale zero error
DO NOT USE “write-overs” (Don’t turn a “6” or “9” into an “8”.)
Never vary your initials or signature
Eg. Weight of material - 14.5 kg 14.75 kg Ams 13/12/07
43
44. Good Documentation PracticesGood Documentation Practices
Use only black or blue permanent
ink. The ink should not run or
smear if the record is splashed with
liquid. All entries must be permanent
and able to be photocopied.
44
Pencil writing is not acceptable,
and able to be photocopied.
Don’t use pens like gel pens, ink pens
for making entries. Don’t use pens
like red, green color ink.
45. Good Documentation PracticesGood Documentation Practices
When portions of a page or a complete page remain unused, a
single line must be drawn angularly across the unused portion.
Sign and date the crossed out section and provide an explanation
Eg- Not applicable; Remining pages not used refer new note
book
Ensure the pagination (all pages to be numbered; could be page X Ensure the pagination (all pages to be numbered; could be page X
of Y for loose sheets and page x.. For bound books)
Make the required entries on the record as the work is
performed.
Do not record information on a
separate piece of paper /temporary
entry and enter on the record later
45
46. Good Documentation PracticesGood Documentation Practices
Use correct rounding off procedures and significant figures
When a comment or explanation is required, make all
statements objective. Avoid personal comments and opinions.
When dating a signature, use the actual day the signature was
signed.
If the activity being recorded occurs on more than one day,
the record must clearly indicate where the "break" occurred.
This can be accomplished by drawing a horizontal line
through the procedure at the break" and indicating the new
date or making entries that are initiated and dated
appropriately.
46
47. Poor Documentation PracticesPoor Documentation Practices
Document error correction not signed/dated, and didn’t include
a reason for the correction
Write-overs, multiple line-through and use of "White-out" or
other masking device
Sample sequence table and audit trail not documented (if its not
documented, it didn’t happen)documented, it didn’t happen)
SOP related to production, calibration, storage and maintenance
not authorized by the QA head
The delegation for the batch release, in case of absence of the QA
manager, not recorded / documented
Out-of-specification (OOS) procedure not detailed enough; flow
chart and /or check-list not available.
47
48. 48
“ I swear to follow the good documentation
practice and document the actual
information at the time of performed …..”
49. Data integrityData integrity issuesissues
Backdating/Postdating/Missing Signatures
• Fabricating/faking data
• Copying existing data as new data
• Releasing failing product
• Hiding/obscuring SOP or protocol deviations• Hiding/obscuring SOP or protocol deviations
• Not saving electronic or hard copy data
• Inadequate reporting of failure and deviation
• Use of non-validated software
• Mismatch between reported data and actual data
• No links/traceability to source documents or original data
49
50. Data integrity issuesData integrity issues
Re-running samples / Test until release
No or Inappropriate Audit Trail
Inadequate Access Authorization/ Privileges
Discarding Deleting of data/ omitting negative data (like OOS or
eliminating outliers)
Not reporting failing results /stability failures Not reporting failing results /stability failures
Conducting unofficial analysis
Disabling audit trails in electronic data capture systems
Fabricating training data
Having unofficial batch sheets and analytical reports
This is not related to training or understanding a particular
technical or quality concept but mainly related to honesty and
ethical issues.
50
51. Typical content in WLTypical content in WL
Firm did not identify, report, or investigate the out-of-
specification (OOS) results.
Firm did not retain any raw data related to sample weights
and sample solution preparations for the HPLC assays….
Repeated the analysis next day using a new set of sample Repeated the analysis next day using a new set of sample
solutions, and reported the retest results in COA
Firm deleted /disregarded OOS data without
investigations, and selectively reported only passing
results.
During inspection, QC Chemist admitted that, under the
direction of a senior colleague, he had recorded false data
in the logbooks for reserve samples
51
52. Typical content in WLTypical content in WL
QC analyst label sample “trial” injections as standard rather than
by the actual sample batch numbers”
Creating passing test results without performing the test
Access control is not implemented in GC, FTIR and HPLC to
prevent unauthorized access and control
Lack of records demonstrating who performed analysis
Raw data not recorded contemporaneously nor by the
performing analyst
Failed injections of QC standards (SS) deleted, repeated and
inserted into the analytical sequence without explanation.
Falsification of batch records (re-writing clean records) Non-
contemporaneous recording of lab data Recording of sample
weights on scraps of paper Missing raw data 52